OBS! Ansökningsperioden för denna annonsen har
passerat.
Arbetsbeskrivning
Job description
We are looking for highly motivated Bioengineers to join our research and development teams. You will be involved in research projects employing cutting edge cellular and molecular biology technologies, and state of the art equipment. The Bioengineer role at Anocca is suited to early-career ambitious scientists with a keen interest in biotechnology and scientific method.
You should already have relevant high-quality experience and hold an MSc in biomedical sciences. You must have excellent English communication skills, deep knowledge of relevant research techniques and the ability to independently analyse and summarise data. You must be capable of working as part of a team but should also demonstrate initiative to drive projects forward.
What we are looking for:
MSc in biomedical sciences or equivalent experience
Significant and relevant laboratory experience in mammalian cell biology with an emphasis on cell culture and flow cytometry
Fluent written and spoken English
It would be nice if you have one or more of the following:
Experience with primary cell culture
Experience with T-cell biology
Experience with cell magnetic cell selection techniques and flow sorting
Experience with immunology research
We offer
An international workplace, with plenty of variety in the job and the opportunity to work, learn and develop at the exciting intersection of biotechnology and medicine.
Application
Applicants should send a CV and detailed cover letter in English to jobs@anocca.com.
Please note that we contact candidates that we would like to invite for an interview within 3 weeks after the advertisement has closed. Unsuccessful candidates will not be contacted.
Anocca AB is a dynamic, fast-moving platform-based biotechnology company, based in modern labs on the Biovation Science Park in Södertälje. We're leading the way to a new generation of cancer therapies that harness the power of the immune system. We are a young group of more than 70 people from over 30 countries, and we aim to grow rapidly.